Cabaletta Bio, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Convertible Preferred Stock (Tables)

Convertible Preferred Stock (Tables)

9 Months Ended

Sep. 30, 2019

The following table summarizes the Company’s Convertible Preferred Stock issued in the nine months ended September 30, 2019 and outstanding as of September 30, 2019:

	Series A Preferred				Series A-1 Preferred				Series A-2 Preferred						Series B Preferred					Total Convertible Preferred Stock
	Shares		Amount		Shares		Amount		Shares			Amount			Shares		Amount			Shares		Amount
Balance—December 31, 2018		3,146,551	$	12,575		7,372,719	$	24,994		1,873,777		$	6,352			—	$	—			12,393,047	$	43,921
Issuance		—		—		—		—		—			—			6,963,788		50,000			6,963,788		50,000
Exchange, including deemed dividend		—		—		—		—		(1,405,332	)		(4,764	)		1,405,332		10,090			—		5,326
Issuance costs		—		—		—		—		—			—			—		(1,293	)		—		(1,293	)
Balance—September 30, 2019		3,146,551	$	12,575		7,372,719	$	24,994		468,445		$	1,588			8,369,120	$	58,797			19,356,835	$	97,954